PAM2L Biotechnologies

Shenzhen, China · Founded 2021 · Privately Held (backing)

Developer of biomaterial innovation and application intended for the synthetic biology sector. PAM2L Biotechnologies is based in Shenzhen, China and was founded in 2021. Its last reported valuation was $88.8 million in Jan 2023. It has raised $19.1 million.

Last reported valuation

$88.8M

Oct 2026

Priced at

—

Total raised

$19.1M

Last round

—

How much has PAM2L Biotechnologies raised?

$19.1Macross 0 recorded rounds

Free account

More of PAM2L Biotechnologies with a free account

·The complete investor list: 11 names
·Watch PAM2L Biotechnologies: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

PAM2L Biotechnologies investors

11 investors are on record for PAM2L Biotechnologies, including Co-Stone Capital, 5Y Capital, Yunqi Partners and Shenzhen Angel Investment Guiding Fund.

For fundraisers

Raising for a company like PAM2L Biotechnologies?

11 investors have backed PAM2L Biotechnologies.

See all 11 investors →

Frequently asked about PAM2L Biotechnologies

How much has PAM2L Biotechnologies raised?: PAM2L Biotechnologies has raised $19.1M in total across 0 recorded funding rounds.